Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models

Published Date: 25 Apr 2025

Pancreatic cancer is a leading cause of cancer-related death, with a five-year survival rate of 13%. The high mortality is largely due to a lack of effective therapy options. In a recent paper published in Nature, researchers ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

United States Lung Cancer Screening Rates Remain Low. s. in particular in the South.

2.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

3.

Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models

4.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

5.

A researcher has found that yoga exhibits the "most improvement" in helping long-term cancer survivors restore their brain health.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot